Source: Annual Congress 2004 - Multicomponent management in pulmonary rehabilitation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. M. W. J. Schols, F. Maltais, D. E. O‘Donnell, P. Hernandez, J. M. Tellier, B. Lussier, S. Allas, A. Chapdelaine, T. Abribat, L. Vachon (Maastricht, The Netherlands; Québec, Kingston, Halifax, Montreal, Canada). Anabolic effects and safety assessments of TH9507, a growth hormone releasing factor (GRF) analog, in patients with COPD-associated wasting. Eur Respir J 2004; 24: Suppl. 48, 1888

Member's Comments

No comment yet.

Related content which might interest you: Effects of TH9507, a growth hormone releasing factor (GRF) analog, on functional performance in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 245s Year: 2004 Growth hormone (GH) response to GH-releasing hormone (GHRH) in asthmatic patients during long-term inhaled corticosteroids (ICS) treatment Source: Eur Respir J 2003; 22: Suppl. 45, 419s Year: 2003 Endocrinological disturbances in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 76S-80S Year: 2003 New serum measures of the insulin like growth factor axis in children with asthma treated with exogenous glucocorticoids Source: Eur Respir J 2006; 28: Suppl. 50, 852s Year: 2006 Endocrinological derangements in COPD Source: Eur Respir J 2009; 34: 975-996 Year: 2009 Role of growth hormone-releasing hormone in sleep and growth impairments induced by upper airway obstruction in rats Source: Eur Respir J 2011; 38: 870-877 Year: 2011 Association of adrenal response in asthmatic children on inhaled steroids with polymorphisms in the genes of glucocorticoid receptor (GR) and corticotropin releasing hormone receptor 1 (CRHR1) Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 Corticosteroid effects on cell signalling Source: Eur Respir J 2006; 27: 413-426 Year: 2006 Sleep apnoea and quality of life in growth hormone deficient adults before and six months following growth hormone therapy Source: Eur Respir J 2005; 26: Suppl. 49, 570s Year: 2005 Autocrine expression of mechano and insulin-like 1 growth factors (MGF & IGF-1) in the diaphragm of severe COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 573s Year: 2003 Serum levels of insulin-like growth factor binding protein-3 and vascular endothelial growth factor in obstructivesleep apnea patients. Effect of CPAP treatment Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 The relationship between thyroid hormones, somatomedin-C (IGF-1), anabolic hormones and the severity of disease in chronic obstructive lung disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 30s Year: 2006 Relationship between structural bone changes assessed by ultrasound bone densitometry (UBD) and growth hormone (GH) during chronic treatment with inhaled corticosteroids (ICS) in asthmatic patients Source: Eur Respir J 2003; 22: Suppl. 45, 419s Year: 2003 Muscle regrowth in COPD patients induced by anabolic steroids is amplified by systemic glucocorticoids (GC): A potentiating interaction between GC and IGF-1? Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable Year: 2011 Growth hormone releasing hormone receptor (GHRH-R) antagonist MIA-602 modulates fibrosis and gene expression in lungs of bleomycin-treated mice Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Alpha-melanocyte stimulating hormone potentially inhibits basophil activation, indicating a novel function of this neuropeptide in airway allergy Source: Annual Congress 2011 - Mechanisms of allergic inflammation of the airways Year: 2011 YS5: The influence of glucocorticoid therapy on trancription factor balance in asthma patients Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease Year: 2011 Growth hormone-releasing hormone receptor antagonist MIA-602 modulates mouse lung inflammation and fibrosis due to bleomycin Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology Year: 2018 Effects of insulin-like growth factor on nitrogen balance during hypoxic exposure Source: Eur Respir J 2002; 20: 293-299 Year: 2002 Differences in the glucocorticoid to progesterone receptor selectivity of inhaled glucocorticoids Source: Eur Respir J 2006; 27: 511-516 Year: 2006